ArticleClinical pharmacology in drug development2021

Phase 1 Study Evaluating the Effects of the Proton Pump Inhibitor Rabeprazole and Food on the Pharmacokinetics of Lorlatinib in Healthy Participants.

Huiping Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.